22:32 Fri 20 Nov 2020
Accrol Group Hldgs - Result of General Meeting
Accrol Group Holdings plc
(the "Company")
AIM: ACRL
Result of General Meeting
Accrol Group Holdings plc, a leading independent tissue converter in the
Following the approval of the Resolutions, the placing to raise
For further information, please contact: |
|
|
|
Accrol Group Holdings plc |
|
|
Via Belvedere Communications |
|
|
|
|
Zeus Capital Limited (Nominated Adviser & Broker) |
|
|
Tel: +44 (0) 161 831 1512 |
|
Tel: +44 (0) 203 829 5000 |
|
|
Liberum Capital Limited (Joint Broker) |
Tel: +44 (0) 20 3100 2222 |
|
|
|
|
Deloitte LLP (Financial Adviser) |
Tel: +44 (0) 20 7936 3000 |
|
|
|
|
Belvedere Communications Limited |
|
|
Tel: +44 (0) 7715 769 078 |
|
Tel: +44 (0) 7967 816 525 |
|
Tel: +44 (0) 7407 023 147 |
|
Notes to Editors
Accrol Group Holdings plc, based in
· |
A manufacturing, storage, and distribution facility in |
· |
A storage and administrative centre in |
· |
A facial tissue plant, also in |
· |
A manufacturing, storage, and distribution facility in Leyland. |
For more information, please visit www.accrol.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE